• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD56 明亮型 CD16 阴性杀伤性免疫球蛋白样受体自然杀伤细胞表现出更长的端粒,并在激活后获得 CD56 暗淡型自然杀伤细胞的特征。

CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.

作者信息

Romagnani Chiara, Juelke Kerstin, Falco Michela, Morandi Barbara, D'Agostino Antonella, Costa Roberta, Ratto Giovanni, Forte Giuseppe, Carrega Paolo, Lui Gabrielle, Conte Romana, Strowig Till, Moretta Alessandro, Münz Christian, Thiel Andreas, Moretta Lorenzo, Ferlazzo Guido

机构信息

Department of Clinical Immunology, German Rheumatism Research Centre, Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany.

出版信息

J Immunol. 2007 Apr 15;178(8):4947-55. doi: 10.4049/jimmunol.178.8.4947.

DOI:10.4049/jimmunol.178.8.4947
PMID:17404276
Abstract

Human NK cells can be divided into CD56(dim)CD16(+) killer Ig-like receptors (KIR)(+/-) and CD56(bright)CD16(-) KIR(-) subsets that have been characterized extensively regarding their different functions, phenotype, and tissue localization. Nonetheless, the developmental relationship between these two NK cell subsets remains controversial. We report that, upon cytokine activation, peripheral blood (PB)-CD56(bright) NK cells mainly gain the signature of CD56(dim) NK cells. Remarkably, KIR can be induced not only on CD56(bright), but also on CD56(dim) KIR(-) NK cells, and their expression correlates with lower proliferative response. In addition, we demonstrate for the first time that PB-CD56(dim) display shorter telomeres than PB- and lymph node (LN)-derived CD56(bright) NK cells. Along this line, although human NK cells collected from nonreactive LN display almost no KIR and CD16 expression, NK cells derived from highly reactive LN, efferent lymph, and PB express significant amounts of KIR and CD16, implying that CD56(bright) NK cells could acquire these molecules in the LN during inflammation and then circulate through the efferent lymph into PB as KIR(+)CD16(+) NK cells. Altogether, our results suggest that CD56(bright)CD16(-) KIR(-) and CD56(dim)CD16(+)KIR(+/-) NK cells correspond to sequential steps of differentiation and support the hypothesis that secondary lymphoid organs can be sites of NK cell final maturation and self-tolerance acquisition during immune reaction.

摘要

人类自然杀伤(NK)细胞可分为CD56(dim)CD16(+)杀伤性免疫球蛋白样受体(KIR)(+/-)和CD56(bright)CD16(-)KIR(-)亚群,关于它们不同的功能、表型和组织定位已进行了广泛的研究。尽管如此,这两个NK细胞亚群之间的发育关系仍存在争议。我们报告称,在细胞因子激活后,外周血(PB)-CD56(bright)NK细胞主要获得CD56(dim)NK细胞的特征。值得注意的是,KIR不仅可在CD56(bright)细胞上诱导表达,也可在CD56(dim)KIR(-)NK细胞上诱导表达,其表达与较低的增殖反应相关。此外,我们首次证明,PB-CD56(dim)NK细胞的端粒比PB来源和淋巴结(LN)来源的CD56(bright)NK细胞短。同样,尽管从无反应性LN收集的人类NK细胞几乎不表达KIR和CD16,但来自高反应性LN、输出淋巴和PB的NK细胞表达大量的KIR和CD16,这意味着CD56(bright)NK细胞可能在炎症期间在LN中获得这些分子,然后作为KIR(+)CD16(+)NK细胞通过输出淋巴循环进入PB。总之,我们的结果表明,CD56(bright)CD16(-)KIR(-)和CD56(dim)CD16(+)KIR(+/-)NK细胞对应于分化的连续步骤,并支持以下假设:二级淋巴器官可能是免疫反应期间NK细胞最终成熟和获得自身耐受性的场所。

相似文献

1
CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.CD56 明亮型 CD16 阴性杀伤性免疫球蛋白样受体自然杀伤细胞表现出更长的端粒,并在激活后获得 CD56 暗淡型自然杀伤细胞的特征。
J Immunol. 2007 Apr 15;178(8):4947-55. doi: 10.4049/jimmunol.178.8.4947.
2
The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic.人类次级淋巴组织中大量的自然杀伤细胞需要激活才能表达杀伤细胞免疫球蛋白样受体并具有细胞溶解活性。
J Immunol. 2004 Feb 1;172(3):1455-62. doi: 10.4049/jimmunol.172.3.1455.
3
New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR Expression.新的 miRNA 特征可预示不同成熟阶段的人类自然杀伤细胞亚群:miR-146a-5p 在调节 KIR 表达中的作用。
Front Immunol. 2018 Oct 15;9:2360. doi: 10.3389/fimmu.2018.02360. eCollection 2018.
4
Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals.在未经治疗的HIV-1血清阳性个体中,CD56(dim)自然杀伤细胞亚群的选择性耗竭及CD56(bright)自然杀伤细胞的维持。
J Clin Immunol. 2002 May;22(3):176-83. doi: 10.1023/a:1015476114409.
5
Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.人类自然杀伤细胞:CD56(明亮型)亚群独特的固有免疫调节作用。
Blood. 2001 May 15;97(10):3146-51. doi: 10.1182/blood.v97.10.3146.
6
Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.杀伤细胞免疫球蛋白样受体(KIR)基因型可预测人类KIR阳性CD56dim自然杀伤细胞对病原体相关信号作出反应的能力。
J Immunol. 2009 May 15;182(10):6426-34. doi: 10.4049/jimmunol.0804224.
7
Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.在黑色素瘤患者区域淋巴结中,CD3(-)CD56(+) NK 细胞上几种激活和抑制受体的分布。
J Surg Res. 2013 Aug;183(2):860-8. doi: 10.1016/j.jss.2013.02.025. Epub 2013 Mar 13.
8
Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56CD16 subset.Toll 样受体 8 激动剂主要通过靶向 CD56CD16 亚群改善 NK 细胞功能。
J Immunother Cancer. 2022 Jan;10(1). doi: 10.1136/jitc-2021-003385.
9
Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.诱导具有抗肿瘤细胞毒性的CD16+ CD56bright自然杀伤细胞,不仅可来自CD16- CD56bright自然杀伤细胞,也可来自CD16- CD56dim自然杀伤细胞。
Scand J Immunol. 2007 Feb;65(2):126-38. doi: 10.1111/j.1365-3083.2006.01883.x.
10
CD56 CD16 Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α.CD56 CD16 自然杀伤细胞表型分析在接受癌症疫苗和干扰素-α治疗的黑色素瘤患者中的应用。
Front Immunol. 2019 Jan 29;10:14. doi: 10.3389/fimmu.2019.00014. eCollection 2019.

引用本文的文献

1
Natural killer cells: the immune frontline against circulating tumor cells.自然杀伤细胞:抵御循环肿瘤细胞的免疫前线。
J Exp Clin Cancer Res. 2025 Apr 10;44(1):118. doi: 10.1186/s13046-025-03375-x.
2
The diversity of natural killer cell functional and phenotypic states in cancer.癌症中自然杀伤细胞功能和表型状态的多样性
Cancer Metastasis Rev. 2025 Jan 24;44(1):26. doi: 10.1007/s10555-025-10242-w.
3
From tumor microenvironment to emerging biomarkers: the reshaping of the esophageal squamous cell carcinoma tumor microenvironment by neoadjuvant chemotherapy combined with immunotherapy.
从肿瘤微环境到新兴生物标志物:新辅助化疗联合免疫治疗对食管鳞状细胞癌肿瘤微环境的重塑
Front Immunol. 2024 Dec 5;15:1478922. doi: 10.3389/fimmu.2024.1478922. eCollection 2024.
4
Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization.自然杀伤细胞功能、信号转导、分子机制及临床应用的综合概述。
Signal Transduct Target Ther. 2024 Nov 8;9(1):302. doi: 10.1038/s41392-024-02005-w.
5
Natural Killer cells at the frontline in the fight against cancer.自然杀伤细胞在抗击癌症的第一线。
Cell Death Dis. 2024 Aug 23;15(8):614. doi: 10.1038/s41419-024-06976-0.
6
Immunology of Cytokine Storm Syndromes: Natural Killer Cells.细胞因子风暴综合征的免疫学:自然杀伤细胞。
Adv Exp Med Biol. 2024;1448:145-159. doi: 10.1007/978-3-031-59815-9_11.
7
Changes in subset distribution and impaired function of circulating natural killer cells in patients with colorectal cancer.结直肠癌患者循环自然杀伤细胞亚群分布改变及功能受损。
Sci Rep. 2024 May 28;14(1):12188. doi: 10.1038/s41598-024-63103-x.
8
Lingering Effects of Early Institutional Rearing and Cytomegalovirus Infection on the Natural Killer Cell Repertoire of Adopted Adolescents.早期机构抚养和巨细胞病毒感染对被收养青少年自然杀伤细胞库的长期影响。
Biomolecules. 2024 Apr 9;14(4):456. doi: 10.3390/biom14040456.
9
Feeder-free differentiation of human iPSCs into natural killer cells with cytotoxic potential against malignant brain rhabdoid tumor cells.将人诱导多能干细胞无饲养层分化为对恶性脑横纹肌样瘤细胞具有细胞毒性潜力的自然杀伤细胞。
Bioact Mater. 2024 Mar 8;36:301-316. doi: 10.1016/j.bioactmat.2024.02.031. eCollection 2024 Jun.
10
Manufacturing CAR-NK against tumors: Who is the ideal supplier?制造用于对抗肿瘤的嵌合抗原受体自然杀伤细胞(CAR-NK):谁是理想的供应商?
Chin J Cancer Res. 2024 Feb 29;36(1):1-16. doi: 10.21147/j.issn.1000-9604.2024.01.01.